“…Importantly, this effect is disrupted in people with schizophrenia (Ford et al, 2013, Ford et al, 2007a, Ford et al, 2001a, Ford et al, 2001b, Ford et al, 2007b, Ford et al, 2010, Heinks-Maldonado et al, 2007), bipolar disorder (Ford et al, 2013), schizotypy (Oestreich et al, 2016), and in people at clinical high risk (CHR) for psychosis (Mathalon et al, 2018). In first-degree relatives of people with schizophrenia and psychotic bipolar disorder, suppression values are intermediate between healthy controls and ill probands (Ford et al, 2013).…”